Showing results (71-80 of 133) with videos related to
Sort By:
Pageof 14
Head & Neck|February 13, 2021
Long-term neck and shoulder function among survivors of oropharyngeal squamous cell carcinoma treated with chemoradiation as assessed with the neck dissection impairment indexSarah J M Burgin, Matthew E Spector, Alexander T Pearson, et al.Head & Neck|December 3, 2009
Chemotherapy alone for organ preservation in advanced laryngeal cancerVasu Divi, Francis P Worden, Mark E Prince, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2010
Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional resultsFelix Y Feng, Hyungjin M Kim, Teresa H Lyden, et al.JAMA Otolaryngology-- Head & Neck Surgery|February 3, 2017
Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal CancerGregory T Wolf, Emily Bellile, Avraham Eisbruch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2013
Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6Elizabeth A Van Tubergen, Rajat Banerjee, Min Liu, et al.Endocrine-Related Cancer|June 3, 2024
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapyMarcia S Brose, Jaume Capdevila, Rossella Elisei, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2008
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II studyEzra E W Cohen, Lee S Rosen, Everett E Vokes, et al.International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosisMatthew H Stenmark, Jonathan B McHugh, Matthew Schipper, et al.The Lancet. Diabetes & Endocrinology|May 3, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statementSophie Leboulleux, Laura Boucai, Naifa Busaidy, et al.JAMA Otolaryngology-- Head & Neck Surgery|December 28, 2013
Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinomaSteven B Chinn, Matthew E Spector, Emily L Bellile, et al.Pageof 14